Chen Zhangguo, Chen Lanfen, Qiao Shuo-Wang, Nagaishi Takashi, Blumberg Richard S
Gastroenterology Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
J Immunol. 2008 May 1;180(9):6085-93. doi: 10.4049/jimmunol.180.9.6085.
The long cytoplasmic tail (CT) isoforms of carcinoembryonic Ag-related cell adhesion molecule 1 (CEACAM1) are expressed on activated human T cells and possess two ITIM motifs in the CT. These isoforms of CEACAM1 are inhibitory for T cell responses initiated by the TCR/CD3 complex with the inhibition dependent upon the ITIMs of CEACAM1 and Src homology 2 domain-containing phosphatase 1 (SHP-1). However, the mechanism by which this inhibition occurs in T cells is unknown. We demonstrate here that the Src family kinase, Lck, and the ability of CEACAM1 to bind homophilically are required for the ITIM phosphorylation of CEACAM1 that is a prerequisite for CEACAM1 association with SHP-1. We further show that CEACAM1 associates with and recruits SHP-1 to the TCR/CD3 complex leading to decreased phosphorylation of CD3-zeta and ZAP-70 and consequently decreased activation of the elements downstream of ZAP-70. This is physiologically relevant because extinction of SHP-1 expression or blockade of homophilic binding by CEACAM1 using a Fab that specifically recognizes the homophilic binding region of human CEACAM1 increases the cytolytic function initiated by the TCR/CD3 complex. These studies show that long CT isoforms of CEACAM1 orchestrate an inhibitory program that abrogates extremely proximal events downstream of the TCR/CD3 complex by focusing on the activation of ZAP-70.
Front Immunol. 2024
Nat Commun. 2025-5-29
J Biol Chem. 2025-4-29
Eur J Clin Invest. 2024-12
J Clin Invest. 2024-11-14
BMC Bioinformatics. 2024-3-21
Genes Cancer. 2023-2-1
Immunol Rev. 2007-8
Eur J Immunol. 2007-5
Nat Rev Immunol. 2006-6
J Clin Invest. 2004-10